Keyphrases
Mycosis Fungoides
100%
Urinary Tract Infection
50%
Clinical Prognosis
50%
Extracorporeal Photopheresis
50%
Cutaneous Graft-versus-host Disease
50%
Clinical Features
50%
Clinical Presentation
50%
Onychomycosis
50%
Nevus
50%
Trichophyton Rubrum
50%
Intravascular Large B-cell Lymphoma (IVLBCL)
50%
Diagnostic Challenge
50%
Skin Biopsy
50%
Racial Disparities
50%
Collaborative Study
50%
Chronic Bullous Disease of childhood
50%
Diagnostic Advances
50%
Chronic Pruritus
50%
Therapeutic Management
50%
Pediatric Patients
50%
Dermatologist
50%
Unexplained Fever
50%
Beau's Lines
50%
Febrile Infant
37%
White People
28%
People of Color
28%
40 Years Old
25%
Cutaneous Neoplasm
25%
Post-transplant Period
25%
Renal Cancer
25%
Urine Culture
25%
Older Women
25%
Solar Lentigo
25%
Verruca Vulgaris
25%
Verruca Plana
25%
Liquid Nitrogen Spray
25%
Thermal Conductive
25%
Rare Cause
25%
All Infections
25%
Black Females
21%
Training Program
16%
Dermatology Residency Programs
16%
Pyrexia
16%
Cutaneous Manifestations
16%
Clonal Proliferation
16%
Non-Hodgkin Lymphoma
16%
Autopsy
16%
Thrombocytopenia
16%
Rate of Return
16%
Anaemia Status
16%
Medicine and Dentistry
Mycosis fungoides
100%
Disease
75%
Bullous Skin Disease
50%
Nevus Sebaceous
50%
White Superficial Onychomycosis
50%
Trichophyton Rubrum
50%
Diagnosis
50%
Therapeutic Management
50%
Photopheresis
50%
Clinical Feature
50%
Pediatrics Patient
50%
Urinary Tract Infection
50%
B-Cell Lymphoma
50%
Racial Disparity
50%
Beau's Lines
50%
Skin Biopsy
50%
Febrile Infant
37%
Dermatology
33%
Breast Melanoma
25%
Graft Versus Tumor Effect
25%
Dermatitis Herpetiformis
25%
Urine Culture
25%
Bullous Dermatitis
25%
Infection
25%
Verruca Plana
25%
Bullous Pemphigoid
25%
Pediatrics
22%
Symptom
22%
Thrombocytopenia
16%
Lymphoblast
16%
Anemia
16%
Non-Hodgkin Lymphoma
16%
Mental Health
16%
Fever
16%
Capillary
16%
Body Surface
14%
Flow Cytometry
7%
Biopsy
7%
Clinician
5%
Patient Preference
5%
Disease Severity
5%
Delayed Diagnosis
5%
Cutaneous Lymphoma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Aprepitant
50%
Urinary Tract Infection
50%
Trichophyton Rubrum
50%
Pruritus
50%
Infection
25%
Postoperative Nausea and Vomiting
14%
Symptom
14%
Breast Carcinoma
7%
Neurokinin 1 Receptor Antagonist
7%
Solid Malignant Neoplasm
7%
Naltrexone
7%
Chemotherapy Induced Nausea and Vomiting
7%
Azathioprine
7%
Ultraviolet Radiation
7%
Chronic Kidney Failure
7%
Antihistaminic Agent
7%
Syndrome
7%
Hyperuricemia
7%
Hodgkin Disease
7%
Gabapentin
7%
Mycosis fungoides
7%
Comorbidity
7%
Iron Deficiency
7%
Sarcoma
7%
Open-Label Trial
7%
Lung Adenocarcinoma
7%
Antipruritic Agent
7%
Methotrexate
7%
Adverse Event
7%
